Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 7636123, 7 pages
http://dx.doi.org/10.1155/2016/7636123
Review Article

Genetic Polymorphism of Angiotensin-Converting Enzyme and Chronic Obstructive Pulmonary Disease Risk: An Updated Meta-Analysis

1Department of Dental Pharmacology, School of Dentistry, Dankook University, Cheonan 31116, Republic of Korea
2Kohwang Medical Research Institute, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
3Division of Allergy and Respiratory System, Department of Korean Internal Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
4Department of Korean Physiology, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea

Received 28 April 2016; Revised 13 September 2016; Accepted 19 September 2016

Academic Editor: Anastasia Kotanidou

Copyright © 2016 Sang Wook Kang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Di Stefano, G. Caramori, F. L. M. Ricciardolo, A. Capelli, I. M. Adcock, and C. F. Donner, “Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview,” Clinical and Experimental Allergy, vol. 34, no. 8, pp. 1156–1167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Soriano and B. Lamprecht, “Chronic obstructive pulmonary disease: a worldwide problem,” The Medical Clinics of North America, vol. 96, no. 4, pp. 671–680, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Soriano and R. Rodríguez-Roisin, “Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation,” Proceedings of the American Thoracic Society, vol. 8, no. 4, pp. 363–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Murray, A. D. Lopez, R. Black et al., “Global burden of disease 2005: call for collaborators,” The Lancet, vol. 370, no. 9582, pp. 109–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. E. Grigoriadis, D. Pearsall, and E. B. De Souza, “Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary,” Neuropsychopharmacology, vol. 2, no. 1, pp. 53–60, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Eisner, N. Anthonisen, D. Coultas et al., “An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 5, pp. 693–718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Blanc, A. M. B. Menezes, E. Plana et al., “Occupational exposures and COPD: an ecological analysis of international data,” The European Respiratory Journal, vol. 33, no. 2, pp. 298–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ezzati, S. V. Hoorn, A. Rodgers, A. D. Lopez, C. D. Mathers, and C. J. L. Murray, “Estimates of global and regional potential health gains from reducing multiple major risk factors,” The Lancet, vol. 362, no. 9380, pp. 271–280, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Joos, P. D. Paré, and A. J. Sandford, “Genetic risk factors for chronic obstructive pulmonary disease,” Swiss Medical Weekly, vol. 132, no. 3-4, pp. 27–37, 2002. View at Google Scholar · View at Scopus
  10. C. M. Yun and X. Y. Sang, “Role of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary disease,” Genetics and Molecular Research, vol. 14, no. 4, pp. 13215–13220, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. E. S. Essa and R. A. El Wahsh, “Association between Plasminogen activator inhibitor-1-675 4G/5G insertion/deletion polymorphism and chronic obstructive pulmonary disease,” COPD, 2016. View at Publisher · View at Google Scholar
  12. W. Wang, P. Li, Y. Chen, and J. Yang, “Association between β2-adrenergic receptor-16Arg/Gly gene polymorphism and chronic obstructive pulmonary disease risk: systematic review and meta-analysis,” Iranian Journal of Public Health, vol. 43, no. 7, pp. 877–888, 2014. View at Google Scholar · View at Scopus
  13. C. Ayada, Ü. Toru, O. Genç et al., “Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population,” Genetics and Molecular Research, vol. 13, no. 4, pp. 10427–10433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Simsek, S. Tekes, D. Oral et al., “The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease,” Genetics and Molecular Research, vol. 12, no. 2, pp. 1392–1398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Busquets, N. G. MacFarlane, D. Heine-Suñer et al., “Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 3, pp. 329–334, 2007. View at Google Scholar · View at Scopus
  16. A. Ahsan, R. Ram, M. A. Baig, and M. A. Q. Pasha, “ACE I allele and eNOS G allele crosstalk may have a role in chronic obstructive pulmonary disease,” Clinical Biochemistry, vol. 37, no. 11, pp. 1037–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Pradhan, E. H. Kemp, M. Nadkar et al., “Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and susceptibility to systemic lupus erythematosus in an Indian population,” Scandinavian Journal of Rheumatology, vol. 44, no. 5, pp. 425–427, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Shanmuganathan, R. Kumaresan, and P. Giri, “Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease,” Journal of Postgraduate Medicine, vol. 61, no. 4, pp. 230–234, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. D. N. Parchwani, M. G. Kesari, D. D. Patel, and D. J. Patel, “Influence of genetic variability at the ACE locus in intron 16 on Diabetic Nephropathy in T1DM patients,” Indian Journal of Physiology and Pharmacology, vol. 58, no. 4, pp. 327–337, 2014. View at Google Scholar · View at Scopus
  20. B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier, “An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels,” Journal of Clinical Investigation, vol. 86, no. 4, pp. 1343–1346, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Barát, G. Böszörményi-Nagy, and L. A. Debreczeni, “Serum angiotensin converting enzyme values in chronic obstructive pulmonary disease,” Acta Physiologica Hungarica, vol. 70, no. 2-3, pp. 337–342, 1987. View at Google Scholar · View at Scopus
  22. B. Al'tshuler, A. P. Roitman, V. V. Dolgov, G. A. Iarovaia, E. A. Neshkova, and T. A. Fedorova, “The change in the activity of angiotensin converting enzyme in patients with pneumonia and chronic obstructive pulmonary diseases,” Klinicheskaia Laboratornaia Diagnostika, no. 1, pp. 10–15, 2002. View at Google Scholar · View at Scopus
  23. K. J. Curtis, V. M. Meyrick, B. Mehta et al., “Angiotensin-converting enzyme inhibition as an adjunct to pulmonary rehabilitation in COPD,” American Journal of Respiratory and Critical Care Medicine, 2016. View at Publisher · View at Google Scholar
  24. H. Seok, S. K. Kim, K. H. Yoo, B. Lee, Y. O. Kim, and J. Chung, “Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population,” Journal of Exercise Rehabilitation, vol. 10, no. 6, pp. 383–388, 2014. View at Publisher · View at Google Scholar
  25. H. K. Park and S. K. Kim, “Promoter polymorphisms of NDUFA4 gene were associated with prostate enlargement of benign prostatic hyperplasia,” Molecular and Cellular Toxicology, vol. 11, no. 4, pp. 401–406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Ulasli, F. O. Eyuboglu, H. Verdi, and F. B. Atac, “Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients,” Molecular Biology Reports, vol. 40, no. 10, pp. 5625–5633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Pabst, B. Theis, A. Gillissen et al., “Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease,” European Journal of Medical Research, vol. 14, no. 4, pp. 177–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Zhang, C. Wang, H. Dai, Y. Lin, and J. Zhang, “Association between angiotensin-converting enzyme gene polymorphisms and exercise performance in patients with COPD,” Respirology, vol. 13, no. 5, pp. 683–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. S. Hopkinson, K. W. Li, A. Kehoe et al., “Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease,” The American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 385–390, 2008. View at Google Scholar · View at Scopus
  30. R. Tkáčová, P. Joppa, B. Stančák, J. Šalagovič, S. Mišíková, and I. Kalina, “The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD,” Wiener Klinische Wochenschrift, vol. 117, no. 5-6, pp. 210–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Yildiz, H. Oflaz, N. Cine, N. Erginel-Ünaltuna, F. Erzengin, and V. Yilmaz, “Gene polymorphisms of endothelial nitric oxide synthase enzyme associated with pulmonary hypertension in patients with COPD,” Respiratory Medicine, vol. 97, no. 12, pp. 1282–1288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. R. J. van Suylen, E. F. Wouters, H. J. Pennings et al., “The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 6, pp. 1791–1795, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Jiang and N. Zhang, “Angiotensin-converting enzyme I/D polymorphism in patients with chronic obstructive pulmonary disease and pneumocardial disease,” Guo Wai Yi Xue, vol. 23, pp. 248–249, 2004 (Chinese). View at Google Scholar
  34. H. Gu, H. Zhang, and L. Yang, “Relationships between polymorphisms of gene coding angiotensin converting enzyme and susceptibility to chronic obstructive pulmonary disease,” Ji Chu Yi Xue Yu Lin Chuang, vol. 23, pp. 174–177, 2003. View at Google Scholar
  35. H. W. Wang, Z. S. Nie, Y. Z. Duan et al., “Association between polymorphism in ACE gene with lung cancer and COPD patients,” Hai Jun Zong Yi Yuan Xue Bao, vol. 13, pp. 203–206, 2000. View at Google Scholar
  36. C. Orte, J. M. Polak, S. G. Haworth, M. H. Yacoub, and N. W. Morrell, “Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension,” Journal of Pathology, vol. 192, no. 3, pp. 379–384, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. V. J. De Beer, H. J. D. De Graaff, M. Hoekstra, D. J. Duncker, and D. Merkus, “Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 6, pp. H1976–H1985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Ueda, H. L. Elliott, J. J. Morton, and J. M. C. Connell, “Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme,” Hypertension, vol. 25, no. 6, pp. 1266–1269, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Firouzabadi, N. Ghazanfari, A. Alavi Shoushtari et al., “Genetic variants of angiotensin-converting enzyme are linked to autism: a case-control study,” PLoS ONE, vol. 11, no. 4, Article ID e0153667, 2016. View at Publisher · View at Google Scholar
  40. H. Kanazawa, T. Okamoto, K. Hirata, and J. Yoshikawa, “Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1235–1238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Munir, S. B. Rahman, S. Rehman et al., “The angiotensin-converting enzyme gene insertion polymorphism: a higher risk for psoriasis in male patients,” The British Journal of Dermatology, vol. 175, no. 4, pp. 824–826, 2016. View at Publisher · View at Google Scholar
  42. T. Sarkar, N. P. Singh, P. Kar et al., “Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients?” Renal Failure, vol. 38, no. 5, pp. 765–769, 2016. View at Publisher · View at Google Scholar
  43. E. A. W. Brice, W. Friedlander, E. D. Bateman, and R. E. Kirsch, “Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD,” Chest, vol. 107, no. 3, pp. 706–710, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. N. A. Kuzubova, A. B. Chukhlovin, E. B. Morozova, A. A. Totolian, and O. N. Titova, “Common intronic D variant of ACE gene is associated with endothelial dysfunction in COPD,” Respiratory Medicine, vol. 107, no. 8, pp. 1217–1221, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Lee, B. G. Nordestgaard, and M. Dahl, “Elevated ACE activity is not associated with asthma, COPD, and COPD co-morbidity,” Respiratory Medicine, vol. 103, no. 9, pp. 1286–1292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. W. Li, F. Lan, F. Yan, and H. Shen, “Angiotensin-converting enzyme I/D polymorphism is associated with COPD risk in Asian population: evidence from a meta-analysis,” Journal of Chronic Obstructive Pulmonary Disease, vol. 10, no. 1, pp. 35–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Li, N. Wei, Z. Wu et al., “The D/I polymorphism in the angiotensin-converting enzyme gene and chronic obstructive pulmonary disease risk: a meta-analysis,” Journal of Chronic Obstructive Pulmonary Disease, vol. 9, no. 5, pp. 485–491, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Barley, A. Blackwood, N. D. Carter et al., “Angiotensin converting enzyme insertion/deletion polymorphism: ASSOCIATION with ethnic origin,” Journal of Hypertension, vol. 12, no. 8, pp. 955–957, 1994. View at Google Scholar · View at Scopus
  49. J. L. Lõpez-Campos, W. Tan, and J. B. Soriano, “Global burden of COPD,” Respirology, vol. 21, no. 1, pp. 14–23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Kim, K. H. Yoo, C. K. Rhee et al., “Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea,” The International Journal of Tuberculosis and Lung Disease, vol. 18, no. 6, pp. 737–743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. J. H. Kim, C. K. Rhee, K. H. Yoo et al., “The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data,” International Journal of COPD, vol. 8, pp. 561–568, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. W.-S. K. Teo, W.-S. Tan, W.-F. Chong et al., “Economic burden of chronic obstructive pulmonary disease,” Respirology, vol. 17, no. 1, pp. 120–126, 2012. View at Publisher · View at Google Scholar · View at Scopus